Evidence from cross-sectional patient-based studies in drug naive schizophrenia patients suggests that high dopamine and subsequently low PRL concentrations [28,29] are related to an increased T2DM risk, including insulin resistance and impaired fasting glucose [30]. Here, PRL is linked to Insulin resistance.